AlphaMadera's AlphaVal page computes Universal Corporation's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag UVV as undervalued, fairly valued, or overvalued.

What is Universal Corporation's fair value?

Fair value for UVV is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value UVV?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from UVV's most recent reported fundamentals.

UVV - Universal Corporation

Price: -- -- | CONSENSUS: Buy DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Moderate

Trading 18.8% below fair value

Current Price $54.52

Bear Case $55.31 1.4% upside ($55.31 - $54.52) / $54.52 = 1.4% $3.95 × 14x P/E

Fair Value $67.16 23.2% upside ($67.16 - $54.52) / $54.52 = 23.2% $3.95 × 17x P/E

Bull Case $79.01 44.9% upside ($79.01 - $54.52) / $54.52 = 44.9% $3.95 × 20x P/E

Adjust Assumptions

P/E Multiple

17.0x

Adjusted EPS

3.95$

Key Value Driver

Normalized P/E multiple (17x base case)

Implied Market Multiple 13.8x

Plain-Language Summary

Applying a 17x P/E to adjusted EPS of $3.95, the base-case value is $67.16 per share. DDM cross-check: $47.49.

Warnings

⚠ The company pays out 87% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.

ℹ Dividend-based valuation: $47.49 (below our primary estimate by 29%). Large gaps may signal the dividend doesn't reflect full earning power.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples